Skip to main content
Proteome Science logoLink to Proteome Science
. 2020 Oct 24;18:9. doi: 10.1186/s12953-020-00166-4

Correction to: Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia

Ju Bai 1, Aili He 1,✉, Chen Huang 2, Juan Yang 2, Wanggang Zhang 1,✉, Jianli Wang 1, Yun Yang 1, Pengyu Zhang 1, Yang Zhang 1, Fuling Zhou 1
PMCID: PMC7585291  PMID: 33110398

Correction to: Proteome Sci (2014) 12:49

https://doi.org/10.1186/s12953-014-0049-y

Following publication of the original article [1], the authors reported an error in Fig. 9, the western-blot bands of PF4 were not correct.

Fig. 9.

Fig. 9

Validation of proteins by immunoblotting. a Levels of the FGA and GSTP1 protein differ among the leukemia cells in distinct ALL groups and normal cells. Weak PF4 immunoreactive bands are seen in newly diagnosed and refractory & relapsed ALL cases. b Densitometry comparison of FGA protein relative to β-actin as determined by western blot analysis in figure a. c Densitometry comparison of GSTP1 protein relative to β-actin as determined by western blot analysis in figure a. d Densitometry comparison of PF4 protein relative to β-actin as determined by western blot analysis in figure a. (FGA: fibrinogen alpha chain; GSTP1: glutathione S-transferase P1; PF4: platelet factor 4; ALL- CR: ALL complete remission; ALL-ND: ALL newly diagnosed; ALL-RR: ALL refractory & relapsed)

The correct Fig. 9 is shown below.

Contributor Information

Aili He, Email: heaili@mail.xjtu.edu.cn.

Wanggang Zhang, Email: zhangwanggang2003@yahoo.com.

Reference

  • 1.Bai J, He A, Huang C, et al. Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia. Proteome Sci. 2014;12:49. doi: 10.1186/s12953-014-0049-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proteome Science are provided here courtesy of BMC

RESOURCES